104 related articles for article (PubMed ID: 27984375)
1. Survival After Pelvic Exenteration for Cervical Cancer: A National Cancer Database Study.
Graves S; Seagle BL; Strohl AE; Shahabi S; Nieves-Neira W
Int J Gynecol Cancer; 2017 Feb; 27(2):390-395. PubMed ID: 27984375
[TBL] [Abstract][Full Text] [Related]
2. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
[TBL] [Abstract][Full Text] [Related]
3. Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study.
Seagle BL; Kanis M; Strohl AE; Shahabi S
Gynecol Oncol; 2016 Dec; 143(3):636-641. PubMed ID: 27771166
[TBL] [Abstract][Full Text] [Related]
4. Survival After Primary Debulking Surgery Compared With Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A National Cancer Database Study.
Seagle BL; Graves S; Strohl AE; Shahabi S
Int J Gynecol Cancer; 2017 Oct; 27(8):1610-1618. PubMed ID: 28763362
[TBL] [Abstract][Full Text] [Related]
5. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
[TBL] [Abstract][Full Text] [Related]
6. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
7. Exenteration as a primary treatment for locally advanced cervical cancer: long-term results and prognostic factors.
Forner DM; Lampe B
Am J Obstet Gynecol; 2011 Aug; 205(2):148.e1-6. PubMed ID: 21640963
[TBL] [Abstract][Full Text] [Related]
8. Does histologic type correlate to outcome after pelvic exenteration for cervical and vaginal cancer?
Baiocchi G; Guimaraes GC; Faloppa CC; Kumagai LY; Oliveira RA; Begnami MD; Soares FA; Lopes A
Ann Surg Oncol; 2013 May; 20(5):1694-700. PubMed ID: 23212765
[TBL] [Abstract][Full Text] [Related]
9. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
[TBL] [Abstract][Full Text] [Related]
10. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer.
Schmidt AM; Imesch P; Fink D; Egger H
Gynecol Oncol; 2012 Jun; 125(3):604-9. PubMed ID: 22406639
[TBL] [Abstract][Full Text] [Related]
11. Data-Derived Treatment Duration Goal for Cervical Cancer: Should 8 Weeks Remain the Target in the Era of Concurrent Chemoradiation?
Hong JC; Foote J; Broadwater G; Sosa JA; Gaillard S; Havrilesky LJ; Chino JP
JCO Clin Cancer Inform; 2017 Nov; 1():1-15. PubMed ID: 30657372
[TBL] [Abstract][Full Text] [Related]
12. Pelvic exenteration for adenocarcinoma of the uterine cervix.
Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
[TBL] [Abstract][Full Text] [Related]
13. The impact of distance to closest negative margin on survival after pelvic exenteration.
Martin AL; Sinha S; Peres LC; Hakam A; Chon HS; Hoffman MS; Shahzad MM; Wenham RM; Chern JY
Gynecol Oncol; 2022 Jun; 165(3):514-521. PubMed ID: 35487774
[TBL] [Abstract][Full Text] [Related]
14. Pattern of Care, Health Care Disparities, and Their Impact on Survival Outcomes in Stage IVB Cervical Cancer: A Nationwide Retrospective Cohort Study.
Jalloul RJ; Sharma S; Tung CS; O'Donnell B; Ludwig M
Int J Gynecol Cancer; 2018 Jun; 28(5):1003-1012. PubMed ID: 29757872
[TBL] [Abstract][Full Text] [Related]
15. Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study.
Seagle BL; Sobecki-Rausch J; Strohl AE; Shilpi A; Grace A; Shahabi S
Gynecol Oncol; 2017 Apr; 145(1):61-70. PubMed ID: 28317559
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience.
Landoni F; Zanagnolo V; Rosenberg PG; Lopes A; Radice D; Bocciolone L; Aletti G; Parma G; Colombo N; Maggioni A
Gynecol Oncol; 2013 Jul; 130(1):69-74. PubMed ID: 23474343
[TBL] [Abstract][Full Text] [Related]
19. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix.
Shingleton HM; Soong SJ; Gelder MS; Hatch KD; Baker VV; Austin JM
Obstet Gynecol; 1989 Jun; 73(6):1027-34. PubMed ID: 2726106
[TBL] [Abstract][Full Text] [Related]
20. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
